Physical Medicine & Rehabilitation, Pain Medicine · Levittown, NY
NPI
1144636754
Since 2014
Specialty
Physical Medicine & Rehabilitation, Pain Medicine
Code 2081P2900X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
100 Jerusalem Ave
Levittown, NY, 11756
Phone (516) 513-0836
Groups this clinician bills Medicare through
Medicare paid, 2024
$595K
6,005 services
Medicare patients, 2024
408
Average age 68
Drug cost, 2024
$1.3M
5,667 prescriptions
Company payments, 2025
$1,713
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Shumail Haque was code 99214 (office e&m - established), 1,848 times for 375 patients. In total Shumail Haque billed 6,005 services in 59 codes, and Medicare paid $595K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-06-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,848 | 375 | $97.84 | $181K |
| 80307 Drug Tests | Office | 1,244 | 229 | $60.90 | $76K |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 738 | 177 | $153.46 | $113K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 438 | 214 | $13.15 | $5,759 |
| G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 337 | 123 | $194.77 | $66K |
| 99213 Office E&M - Established | Office | 205 | 107 | $68.99 | $14K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 117 | 19 | $0.80 | $93.59 |
| 64493 Nerve Block Injection - Back | Office | 66 | 55 | $218.51 | $14K |
| 64494 Nerve Block Injection - Back | Office | 66 | 55 | $111.44 | $7,355 |
| 64483 Nerve Block Injection - Back | Office | 65 | 50 | $264.59 | $17K |
| 64484 Nerve Block Injection - Back | Office | 59 | 41 | $114.14 | $6,734 |
| 64491 Nerve Block Injection - Back | Office | 51 | 40 | $116.55 | $5,944 |
| 64490 Nerve Block Injection - Back | Office | 48 | 40 | $231.18 | $11K |
| 20610 Joint Injection | Office | 38 | 33 | $59.42 | $2,258 |
| 62370 Musculoskeletal | Office | 36 | 14 | $71.02 | $2,557 |
By year: 2022 $280K for 2,679 services; 2023 $580K for 5,709 services; 2024 $595K for 6,005 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80307 Drug Tests | 1,244 | 229 | $60.90 | $76K |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 738 | 177 | $153.46 | $113K |
| G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 337 | 123 | $194.77 | $66K |
Medicare prescription drug claims, 2024
In 2024, the drug Shumail Haque prescribed most often to Medicare patients was Oxycodone Hcl, with 899 prescriptions and refills. In total Shumail Haque wrote 5,667 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone Hcl Generic | 899 | 899 | 165 | $18K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 855 | 855 | 166 | $32K |
| Gabapentin Generic | 409 | 434 | 88 | $3,949 |
| Tizanidine Hcl Generic | 294 | 298 | 51 | $1,636 |
| Morphine Sulfate Er Morphine Sulfate | 269 | 269 | 44 | $6,638 |
| Diclofenac Sodium Generic | 220 | 242 | 66 | $37K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 218 | 218 | 51 | $4,806 |
| Budesonide Er Budesonide | 189 | 189 | 31 | $643K |
| Oxycontin Oxycodone Hcl | 181 | 181 | 33 | $146K |
| Cyclobenzaprine Hcl Generic | 132 | 144 | 30 | $676 |
| Movantik Naloxegol Oxalate | 127 | 137 | 27 | $55K |
| Zolpidem Tartrate Generic | 107 | 107 | 16 | $558 |
| Pregabalin Generic | 104 | 104 | 29 | $1,754 |
| Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl | 98 | 98 | 20 | $13K |
| Tramadol Hcl Generic | 96 | 96 | 24 | $627 |
Brand drugs: 912 claims; generic drugs: 4,755 claims; opioid claims: 2,888.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Shumail Haque $1,713 ($1,713 in general payments such as food, travel and fees) from 15 companies. The largest payer was Abbvie Inc. with $406.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 20 | $406 |
| Collegium Pharmaceutical, Inc. COLL | 17 | $261 |
| Vertex Pharmaceuticals Incorporated VRTX | 7 | $177 |
| Valinor Pharma, LLC | 23 | $175 |
| Axsome Therapeutics, Inc. AXSM | 4 | $103 |
| Indivior Inc. INDV | 4 | $99.6 |
| Protega Pharmaceutials Inc | 5 | $94.79 |
| Scilex Pharmaceuticals Inc. | 4 | $83.41 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 4 | $81.08 |
| Orexo US, Inc. | 3 | $55.23 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.